Answers are grounded in this paper and cite their sources.
Macrolide-resistant Mycoplasma pneumoniae (MRMP) has reached crisis prevalence—97.1% of 421 isolates in a 2023–2024 multicenter survey in China and more than 90% across twenty provinces—while the pediatric formulary remains confined to three antibiotic classes that all act on intracellular housekeeping machinery. No mechanism-diverse drug exists for this pathogen, in part because covalent anchoring strategies have lacked trigger-site knowledge for bacterial surface proteins. Here we address that gap computationally through a proteome-scale tyrosine-trigger screen of thirteen M. pneumoniae surface proteins (82 qualifying hits), corroboration against experimental cryo-electron-microscopy structures (PDB 8A9A and 9GVG), antibody-epitope and pocket mapping, and conservation analysis across four complete genomes spanning both dominant P1 genotypes (P1-1 and P1-2). The screen identified the essential lipid-acquisition protein P116 as the sole Tier-1 target. Four trigger tyrosines (Tyr671, Tyr566, Tyr188, Tyr206) display phenol-hydroxyl solvent-accessible surface areas of 35.2–43.5 Ų in the physiological dimer, and Tyr398 resides inside a validated monoclonal-antibody epitope (residue SASA 52.4 Ų on the isolated P116 chain of the 9GVG complex; 31.9 Ų in the antibody-bound state). A 533 ų subsidiary pocket lies only 2.7 Å from Tyr671, but its entrance aperture measures only 4.0–4.5 Å—too narrow for any aromatic ring (in-plane widths: benzene 7.02 Å, naphthalene 7.36 Å)—which forced an architecture inversion: the recognition group was moved from the anchor end of the conjugate to the leaving-group side of the electrophilic warhead, so that binding occurs in a solvent-side groove without crossing any aperture. The resulting lead, K2 (C₂₉H₂₇FN₂O₈PS⁻, monoisotopic mass 613.1215 Da; two-carbon tether), achieves a qualifying docked-pose fraction of 0.85 (range 0.80–0.90 across four random seeds; 0.78 on an independent seed set), with a median warhead-P···Tyr671-OH distance of 5.60 Å, whereas the warhead-inactivated control K2-N scores 0.00 and the two top-scoring compounds by docking score (− 10.62 and − 10.45 kcal/mol) produce zero qualifying poses—motivating ranking by pose fraction rather than docking score. Successful exchange of K2 is predicted to generate a + 375.0421 Da covalent adduct, a proposed intact-protein mass-spectrometry readout. All eighteen trigger sites are invariant across the four genomes. Because the organism colonizes the airway lumen extracellularly, the design is compatible with nebulized local delivery at the site of infection. This work proposes the first proximity-triggered covalent antibacterial strategy and delivers a conservation-anchored target map together with synthetically tractable, architecture-inverted conjugate designs, providing a defined experimental path toward mechanism-diverse agents against MRMP.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: